Bowel Disease
Conditions
Keywords
mindfulness, quality of life, Bowel Disease
Brief summary
Aim: To compare the effects of a specific application of Mindfulness vs. Treatment-asusual control group in patients with bowel disease. Design: randomized controlled trial. Setting: Outpatient setting. Population: patients who attended bimonthly check up.
Detailed description
Background: Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition with a relapsing disease course. Managing the relapsing nature of the disease causes daily stress for IBD patients. Mindfulness-based Cognitive Therapy (MBCT) is an evidence-based psychological program designed to help manage depressive and stress symptoms. Aim: To compare the effects of a specific application of Mindfulness vs. Treatment-as usual control group in patients with bowel disease. Outcome measures: quality of life, inflammatory and stress markers. Design: randomized controlled trial. Setting: Outpatient setting. Population: patients who attended bimonthly check up.
Interventions
BEHAVIORALMindfulness
Mindfulness-based therapy has been used effectively to treat a variety of physical and psychological disorders, including depression, anxiety, and chronic pain. Recently, several lines of research have explored the potential for mindfulness-therapy in treating somatization disorders, including fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome. Mindfulness-based therapies (MBT) are a clinical application involving the key element of nonjudgmental acceptance of physical pain or psychological distress, thereby reducing the tendency to ruminate over and catastrophise these experiences. In the present study, we propose a mindfulness intervention of 12 months, with sessions either personalized or online.
Sponsors
Cardenal Herrera University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* patients with bowel disease diagnostic * patients with non active disease symptoms in the last 3 month * patients with access to internet and basic informatic knowledge
Exclusion criteria
* active disease symptoms * planned surgery * cognitive impairment * previous experience with mindfulness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life measured with the IBDQ-32 (Inflammatory Bowel Disease Questionnaire) | Change from Baseline IBDQ-32 score at 12 months |
Secondary
| Measure | Time frame |
|---|---|
| inflammation stress markers (reactive Protein C and faecal calprotectin) | Change from Baseline inflammation stress markers at 12 months |
Countries
Spain
Outcome results
None listed